Effect of the angiotensin-converting enzyme inhibitor zofenopril on ocular hydro- and hemodynamics in rabbits with experimental glaucoma
DOI:
https://doi.org/10.31288/oftalmolzh202564247Keywords:
glaucoma, pathogenesis, ACE inhibitor zofenopril, intraocular pressure, ocular hydrodynamics, ocular hemodynamics, rheographic quotient, experimentAbstract
Purpose: To assess the effect of the angiotensin-converting enzyme (ACE) inhibitor zofenopril on the intraocular pressure (IOP), rheographic quotient (RQ) and tonographic parameters of the eye in a rabbit model of adrenaline-induced glaucoma (AIG).
Methods: In group 1 (12 animals), experimental glaucoma was induced by injecting 1:1000 adrenaline 0.1 ml through the auricle vein every other day for 3 months (40 injections totally). In group 2 (12 animals), glaucomatous animals received an aqueous suspension (1 ml) of zofenopril orally at a dose of 1 mg/kg daily for 3 months. The control group comprised 10 intact rabbits. Rabbit eyes were assessed by ophthalmoscopy and biomicroscopy. A Maklakoff tonometer was used for IOP measurements. Ocular hydro- and hemodynamics were assessed. The Kruskal-Wallis and Mann-Whitney tests were employed to assess group differences.
Results: In group 1, mean IOP statistically significantly increased by 28.3%, 34.2% and 46.7% at days 30, 60 and 90, respectively, compared to baseline (р < 0.05). Additionally, mean IOP statistically significantly increased at all time points compared to controls. In group 2, at day 60 and day 90, IOP was 19.6% and 29.6% lower, respectively, compared to group 1. In non-treated glaucomatous animals, at day 90, RQ was decreased by 37.0%, tonographic aqueous humor (AH) outflow facility (C) was decreased by 36.8%, AH production was increased by 23.0% and tonographic IOP (P0) was increased by 61.4% compared to controls. In glaucomatous animals treated with zofenopril, at day 90, RQ and C were 45.7% and 41.7%, respectively, higher, and AH production and P0 were 24.1% and 22.4%, respectively, lower compared to non-treated glaucomatous animals.
Conclusion: In rabbits with AIG, ocular blood flow and ocular hydrodynamics parameters were impaired in the presence of elevated IOP. Zofenopril had a beneficial effect on the function of eyes with AIG (i.e., the IOP, parameters of ocular hemodynamics and AH circulation).
References
1. Chan JW, Chan NCY, Sadun AA. Glaucoma as Neurodegeneration in the Brain. Eye Brain. 2021;13:21-28. https://doi.org/10.2147/EB.S293765
2. Bou Ghanem GO, Wareham LK, Calkins DJ. Addressing neurodegeneration in glaucoma: Mechanisms, challenges, and treatments. Prog Retin Eye Res. 2024;100:101261. https://doi.org/10.1016/j.preteyeres.2024.101261
3. Nislawati R, Taufik Fadillah Zainal A, Ismail A, Waspodo N, Kasim F, Gunawan AMAK. Role of hypertension as a risk factor for open-angle glaucoma: a systematic review and meta-analysis. BMJ Open Ophthalmol. 2021;6(1):e000798. https://doi.org/10.1136/bmjophth-2021-000798
4. Mikheytseva IM. [Role of trigger endothelial, neuronal and integrative mechanisms in the development of glaucomatous process and new pathogenetic therapeutic approaches to primary glaucoma]. [Dissertation for the Degree of Dr Sc (Biol)]. Lugansk; 2013. Ukrainian.
5. Luo X, Shen YM, Jiang MN, Lou XF, Shen Y. Ocular Blood Flow Autoregulation Mechanisms and Methods. J Ophthalmol. 2015;2015:864871. https://doi.org/10.1155/2015/864871
6. Zhang CJ, Jin ZB. Homeostasis and dyshomeostasis of the retina. Curr Med. 2023;2(4). https://doi.org/10.1007/s44194-023-00021-6
7. Alarcon-Martinez L, Shiga Y, Villafranca-Baughman D, Cueva Vargas JL, Vidal Paredes IA, Quintero H, et al. Neurovascular dysfunction in glaucoma. Prog Retin Eye Res. 2023;97:101217. https://doi.org/10.1016/j.preteyeres.2023.101217
8. Wang X, Wang M, Liu H, Mercieca K, Prinz J, Feng Y, et al. The Association between Vascular Abnormalities and Glaucoma - What Comes First? Intern J Mol Sciences.2023;24(17):13211. https://doi.org/10.3390/ijms241713211
9. Szewczuk A, Wawrzyniak ZM, Szaflik JP, Zaleska-Żmijewska A. Is Primary Open-Angle Glaucoma a Vascular Disease? Assessment of the Relationship between Retinal Arteriolar Morphology and Glaucoma Severity Using Adaptive Optics. Journal of Clinical Medicine. 2024;13(2):478. https://doi.org/10.3390/jcm13020478
10. Arrigo A, Aragona E, Saladino A, Arrigo D, Fantaguzzi F, Battaglia Parodi M, et al. Cognitive Dysfunctions in Glaucoma: An Overview of Morpho-Functional Mechanisms and the Impact on Higher-Order Visual Function. Front Aging Neurosci. 2021;13:747050. https://doi.org/10.3389/fnagi.2021.747050
11. Zhou W, Sabel BA. Vascular dysregulation in glaucoma: retinal vasoconstriction and normal neurovascular coupling in altitudinal visual field defects. EPMA J. 2023;14(1):87-99. https://doi.org/10.1007/s13167-023-00316-6
12. Fernández-Albarral JA, Ramírez AI, de Hoz R, Matamoros JA, Salobrar-García E, Elvira-Hurtado L, et al. Glaucoma: from pathogenic mechanisms to retinal glial cell response to damage. Front Cell Neurosci.2024;18:1354569.https://doi.org/10.3389/fncel.2024.1354569
13. Holappa M, Vapaatalo Н, Vaajanen А. Many Faces of Renin-angiotensin System - Focus on Eye. Open Ophthalmol. J. 2017; 19(11):122-42. https://doi.org/10.2174/1874364101711010122
14. Donnarumma E, Ali MJ, Rushing АМ et al. Zofenopril Protects Against Myocardial Ischemia-Reperfusion Injury by Increasing Nitric Oxide and Hydrogen Sulfide Bioavailability. J Am Heart Assoc. 2016; 5. e003531.https://doi.org/10.1161/JAHA.116.003531
15. Bucci M, Vellecco V, Cantalupo А. et al. Hydrogen sulfide accounts for the peripheral vascular effects of zofenopril independently of ACE inhibition. Cardiovasc. Res. 2014;102(1):138-47. https://doi.org/10.1093/cvr/cvu026
16. Mikheytseva I, Kolomiichuk S, Siroshtanenko T. The role of changes in the hydrogen sulfide level in eye tissues on the development of experimental glaucoma. Fiziol Zh. 2024; 70(6), 24-30. https://doi.org/10.15407/fz70.06.024
17. Mikheytseva IN. [Glaucoma models: advantages and shortcomings. Adrenaline-induced glaucoma as an adequate model of human glaucomatous process]. Oftalmol Zh. 2011;3:89-92. Russian.
18. Wagenmakers E, Kucharský Š, van Doorn J, van den Bergh D. Accessible and Sustainable Statistics with JASP. 2023.https://doi.org/10.31234/osf.io/ud2vj
19. Wareham LK, Calkins DJ. The Neurovascular Unit in Glaucomatous Neurodegeneration. Front Cell Dev Biol. 2020;8:452.https://doi.org/10.3389/fcell.2020.00452
20. Feng Y, Prokosch V, Liu H. Current Perspective of Hydrogen Sulfide as a Novel Gaseous Modulator of Oxidative Stress in Glaucoma. Antioxidants (Basel). 2021;10(5):671. https://doi.org/10.3390/antiox10050671
21. Salvi A, Bankhele Р, Jamil J et al. Effect of Hydrogen Sulfide Donors on Intraocular Pressure in Rabbits. 2016;32(6) :371-75. https://doi.org/10.1089/jop.2015.0144
22. Mikheytseva IN, Kolomiichuk SG, Siroshtanenko TI. Тherapy with the angiotensin-converting enzyme inhibitor zofenopril as a new direction in the treatment of primary glaucoma. In: The Functioning of Healthcare in EU Countries and Ukraine in Maintaining Sustainable Development (March 19-20, 2025. Riga, the Republic of Latvia): International scientific conference. Riga, Latvia: Baltija Publishing:45-8. https://doi.org/10.30525/978-9934-26-549-5-11
23. Kulkarni KH, Monjok EM, Zeyssig R at al. Effect of Hydrogen Sulfide on Sympathetic Neurotransmission and Catecholamine Levels in Isolated Porcine Iris-Ciliary Body. Neurochem. Res. 2009; 34: 400-06.https://doi.org/10.1007/s11064-008-9793-7
24. Shnayder NA, Petrova ММ, Popova ТЕ et al. Prospects for the personalized multimodal therapy approach to pain management via action on NO and NOS. Molecules. 2021;26(9). https://doi.org/10.3390/molecules26092431
25. Wallace JL, Ferraz JG, Muscara MN. Hydrogen sulfide: an endogenous mediator of resolution of inflammation and injury. Antioxid. Redox Signal. 2012;17(1):58-67. https://doi.org/10.1089/ars.2011.4351
26. Tang G, Wu L, Liang W, Wang R. Direct stimulation of K(ATP) channels by exogenous and endogenous hydrogen sulfide in vascular smooth muscle cells. Mol Pharmacol. 2005; 68(6):1757-64. https://doi.org/10.1124/mol.105.017467
27. Terzuoli E, Monti М, Vellecco V et al. Characterization of zofenoprilat as an inducer of functional angiogenesis through increased H2S availability. Br J Pharmacol. 2015;172(12):2961-73.https://doi.org/10.1111/bph.13101
28. Cyr AR, Huckaby LV, Shiva SS, Zuckerbraun BS. Nitric Oxide and Endothelial Dysfunction. Crit Care Clin. 2020;36(2):307-321.https://doi.org/10.1016/j.ccc.2019.12.009
29. Reina-Torres E, De Ieso ML, Pasquale LR, Madekurozwa M, van Batenburg-Sherwood J, Overby DR, et al. The vital role for nitric oxide in intraocular pressure homeostasis. Prog Retin Eye Res. 2021;83:100922. https://doi.org/10.1016/j.preteyeres.2020.100922
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Mikheytseva I.M., Khramenko N.I., Kolomiichuk S.G., Siroshtanenko T.I., Alobisi Maiar
This work is licensed under a Creative Commons Attribution 4.0 International License.
This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) that allows users to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author as long as they cite the source.
COPYRIGHT NOTICE
Authors who publish in this journal agree to the following terms:
- Authors hold copyright immediately after publication of their works and retain publishing rights without any restrictions.
- The copyright commencement date complies the publication date of the issue, where the article is included in.
DEPOSIT POLICY
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) during the editorial process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work with an acknowledgement of its initial publication in this journal.
- Post-print (post-refereeing manuscript version) and publisher's PDF-version self-archiving is allowed.
- Archiving the pre-print (pre-refereeing manuscript version) not allowed.
